Lipolytic Injection OEM: Custom, Compliant Fat Dissolving Manufacturing for Global Aesthetic Brands

In 2022, we connected with Marta, a founder of a small aesthetic brand based in Barcelona. She had spent 18 months building an Instagram following for her body contouring line, and decided to launch her own branded lipolytic injection to capture demand from local medspas. She picked a local small-batch manufacturer because their per-unit price was 30% lower than other quotes, and placed an order for 1,200 vials. Three months after launch, she received 17 formal complaints from clinics: patients reported hard, tender lumps at injection sites that lasted more than two weeks, and three patients developed permanent post-inflammatory hyperpigmentation. When local health authorities audited her supplier, they found the facility operated without ISO 13485 certification, and the product had no valid CE marking for medical device sales. Marta was left with €27,000 in unsellable inventory, and had to issue refunds to every clinic that stocked her product.

Stories like Marta’s are far too common in the lipolytic injection supply space. As demand for non-surgical fat reduction continues to climb—driven by consumer preference for no-downtime, low-risk body contouring options—more brands are looking to launch their own branded lipolytic lines, but many underestimate how much rigor goes into manufacturing a safe, effective, compliant injectable product. Lipolytic injections work by delivering precisely measured doses of active ingredients (most commonly pharmaceutical-grade deoxycholic acid and phosphatidylcholine) into targeted subcutaneous fat layers. These ingredients break down fat cell membranes, allowing the body to naturally process and eliminate the released fat over a period of 1-3 weeks. When formulated and manufactured correctly, these injections deliver visible results for areas like submental fat (double chin), upper arm flab, love handles, and small pockets of abdominal fat, with minimal downtime for patients. When made in unregulated facilities with untested ingredient ratios, they can cause tissue necrosis, uneven fat loss, scarring, and long-term skin discoloration.

What Separates a Reliable Lipolytic Injection OEM Partner from Low-Cost Alternatives

Many new brands fixate on per-unit cost first when sourcing an OEM manufacturer, but price alone tells you very little about the total value you will get. A manufacturer that cuts corners on raw material purity, clean room standards, or quality testing will cost you far more in returned inventory, regulatory fines, and reputational damage than you save on upfront production costs. There are a few non-negotiable factors to vet before signing a production contract:

• Valid, market-specific certifications: Any facility producing injectable products should hold ISO 13485 certification, follow Class III medical device production standards, and hold relevant market certifications like CE marking for the EU or FDA registration for US market access. Ask for physical copies of these documents, and verify they are current before placing an order.
• Proven formulation stability: Lipolytic formulas require precise pH balancing and ingredient ratios to avoid damaging non-fat tissue. Ask for clinical safety data, adverse event rate reports, and customer references from other brands that have used the formula.
• Flexible customization options: A one-size-fits-all formula will not work for every market. Clients in Southeast Asia, for example, often need lower active concentrations to match thinner subcutaneous fat layers, while clients in the Middle East and North America may request higher concentrations to reduce the number of required treatment sessions.
• Transparent quality control processes: The manufacturer should test every batch of raw material and every batch of finished product for purity, sterility, and ingredient concentration, and provide batch-specific quality reports with every order.

AIMA International: 20+ Years of Injectable Manufacturing Expertise

AIMA International Group Co., Ltd. was founded in 2003 as a specialized manufacturer of medical aesthetic injectables, and has been named one of the Top 10 Dermal Filler Manufacturers in the global market. Our operation is built to eliminate the exact pain points brands like Marta faced when working with unqualified suppliers.

We operate a 4,800 square meter modern production base, outfitted with Class 100 GMP clean rooms and three dedicated, fully automated production lines. Every step of production follows strict ISO 13485 quality management system standards, and our facilities meet Class III medical device production requirements. We regularly invite third-party auditors from SGS to inspect our production lines and raw material storage processes, to ensure we maintain consistent quality across every batch.

Our R&D team holds patents for two core production technologies: NASHA (Non-Animal Stabilized Hyaluronic Acid) and HICE (High Concentration & Uniform Crosslinking Efficiency). For our lipolytic injection formulations, the HICE technology is particularly valuable: it wraps active deoxycholic acid molecules in micron-sized slow-release carriers, which prevent the active ingredient from diffusing into surrounding connective tissue and blood vessels after injection. This cuts post-injection swelling and bruising time by 40% compared to standard unencapsulated formulas, and reduces the risk of lumps, uneven fat loss, and tissue damage. We use only medical-grade, non-animal sourced raw materials for all our injectables, including a high-purity hyaluronic acid grade that costs $45,000 per kilogram. All our raw material suppliers hold CE GMP certification, and every incoming batch of material goes through three rounds of quality testing before it is allowed onto the production floor. To date, our R&D team has developed more than 1,000 mature, market-tested formulations across dermal fillers, skin boosters, regenerative injectables, and fat dissolving products, so clients do not need to invest months or hundreds of thousands of dollars into new formula development.

Our most requested formulation for lipolytic injection OEM projects is our signature Fat dissolving injectable.

This formula has been refined over 12 years of market use across 30+ countries, with a recorded adverse reaction rate 62% lower than the industry average. The base formula uses a clinically validated concentration of deoxycholic acid, balanced with anti-inflammatory and skin-soothing ingredients to cut down recovery time. Most patients see visible fat reduction in treated areas 1-2 weeks after their second session, with no need for post-treatment massage or extended downtime. Unlike many generic fat dissolving products on the market, our formula is designed to leave skin smooth and tight after fat reduction, with no dimpling or sagging, thanks to the added NASHA-grade hyaluronic acid that supports skin structure during the fat elimination process. Clients can work with our R&D team to adjust the formula for specific use cases: add lidocaine to reduce injection pain, blend in PDRN to boost skin rejuvenation alongside fat reduction, or tweak viscosity to suit shallow facial fat injections vs. deeper body fat treatments.

Flexible OEM Solutions for Brands at Every Stage of Growth

We work with every type of client, from independent estheticians launching their first product line to large, multi-location medspa chains and global aesthetic distributors. In 2023, we partnered with Glow Aesthetics, a 12-location medspa chain based in Dubai. Prior to working with us, the chain stocked a generic, widely distributed fat dissolving product that was available to every competitor in the region. They faced two consistent issues: first, the standard formula concentration was too low for many of their clients, who tended to have thicker subcutaneous fat layers in the face and abdomen, requiring an average of 5 sessions to see desired results. Second, because the product was sold openly to every clinic and online retailer, the chain could not maintain consistent pricing, and many clients chose to buy the product elsewhere for lower prices instead of booking treatments at their locations.

Our team worked with Glow Aesthetics to adjust our core Fat dissolving formula, increasing active ingredient concentration by 15% and adding a lymphatic drainage support complex to cut treatment time down to an average of 3 sessions. Our design team created custom, gold-foil stamped packaging that matched the chain’s luxury brand identity, with serialized labels to prevent unauthorized resale and product diversion. Six months after launching their custom branded lipolytic injection, Glow Aesthetics reported a 35% increase in fat reduction treatment revenue, a 47% client repeat booking rate, and zero incidents of product diversion to unauthorized sellers.

We meet clients where they are, with a full suite of OEM services that remove the friction of launching a new injectable product:

• Full brand and packaging support: Our in-house design team supports clients from initial brand positioning, creating custom logo designs, packaging mockups, and outer box options ranging from simple clinical packaging to luxury gift sets for high-end medspas. We can also provide guidance on marketing claims that are compliant with regional advertising regulations for medical aesthetics.
• Custom formula tweaks: Clients can adjust active ingredient concentrations, add complementary ingredients (such as lidocaine for reduced injection discomfort, PDRN for added skin rejuvenation, or firming peptides to reduce post-treatment sagging), and adjust product viscosity to match specific injection depth requirements for face vs. body treatments.
• No MOQ pressure for emerging brands: We do not enforce rigid high minimum order quantities for new brands, so you can place small test batches to validate market demand before scaling up, without tying up capital in excess inventory. For larger clients placing annual bulk orders, we offer tiered volume discounts to improve your profit margins.
• Reliable production timelines: Sample orders are shipped within 3-5 working days, so you can test formula texture, effect, and packaging quality before committing to a bulk run. Standard bulk orders are produced and shipped within 15-20 days, and we offer expedited production options for clients working against tight product launch deadlines.

Our production lines support a monthly output of up to 50,000 vials and syringes, with a total annual production capacity of 5 million units. This means we can scale with your brand as you grow, from your first 100-unit test batch to multi-hundred-thousand unit annual orders, without production delays or quality drops during peak demand seasons. To date, we have delivered custom OEM solutions for more than 521 aesthetic brands across 37 countries.

Compliance and After-Sales Support to Protect Your Brand

Regulatory risk is one of the biggest threats to any brand selling injectable aesthetic products. We take full responsibility for the manufacturing quality of every product we produce, and provide full documentation support to make market entry as smooth as possible for our clients. Every batch of product ships with batch-specific quality test reports, sterility certificates, and traceability codes. For clients completing local market registration, we provide full access to our facility certifications, CE marking documentation, FDA VCRP registration records, and raw material safety data sheets, to speed up the approval process.

All Medical Aesthetics Wholesale orders placed through our official platform supplierfiller.com come with dedicated after-sales support. A single account manager is assigned to every client, to answer questions about production timelines, shipping, or product usage throughout the partnership. If shipments arrive with damaged goods, packaging errors, or other issues, our team will provide a resolution (including free replacements or refunds as needed) within 48 hours of receiving your claim. We also provide all OEM clients with access to our full library of product training materials, including recommended injection depths, treatment protocols, and guidance for managing common mild post-treatment reactions, so your clinical team can deliver safe, consistent results to patients.

The global non-surgical fat reduction market will continue to grow as more consumers seek out low-downtime alternatives to liposuction, but success in this space depends on selling a product that delivers consistent, safe results for patients. Cutting corners on manufacturing to save a few cents per unit will erode client trust and expose your business to unnecessary risk. If you are exploring lipolytic injection OEM options, you can reach out to our team via supplierfiller.com to request free product samples, review our certification documents, and get a custom quote tailored to your brand’s specific needs. We can walk you through formula options, packaging choices, and timelines, so you can launch your custom fat dissolving line without the common headaches of working with untested manufacturers.